These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17610036)

  • 1. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.
    Zahariou A; Karamouti M; Karagiannis G; Papaioannou P
    Int Urol Nephrol; 2008; 40(1):65-9. PubMed ID: 17610036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial.
    Valiquette G; Herbert J; Maede-D'Alisera P
    Arch Neurol; 1996 Dec; 53(12):1270-5. PubMed ID: 8970454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity.
    Lee HW; Choo MS; Lee JG; Park CH; Paick JS; Lee JZ; Han DH; Park WH; Lee KS
    J Korean Med Sci; 2010 Dec; 25(12):1792-7. PubMed ID: 21165296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2019 Feb; 38(2):563-571. PubMed ID: 30653737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Desmopressin to Treat Nocturnal Polyuria in Elderly Men: Effects on Sleep Quality.
    Kim SO; Yu HS; Kwon D
    Urol Int; 2016; 96(4):438-42. PubMed ID: 26836495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower Urinary Tract Symptoms: What's New in Medical Treatment?
    Peyronnet B; Brucker BM; Michel MC
    Eur Urol Focus; 2018 Jan; 4(1):17-24. PubMed ID: 29665997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP; Herschorn S; Albei CD; van der Meulen EA
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index.
    Hajdinjak T; Leskovar J
    ScientificWorldJournal; 2013; 2013():878564. PubMed ID: 24223034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P; Rezapour M; Cortesse A; Thüroff J; Riis A; Nørgaard JP
    Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for nocturia in the elderly patient.
    Asplund R
    Drugs Aging; 2007; 24(4):325-43. PubMed ID: 17432926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDAVP in the urological management of the difficult neurogenic bladder in spinal cord injury: preliminary report.
    Chancellor MB; Rivas DA; Staas WE
    J Am Paraplegia Soc; 1994 Oct; 17(4):165-7. PubMed ID: 7869058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP
    BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron.
    Zachariou A; Filiponi M; Baltogiannis D; Giannakis J; Dimitriadis F; Tsounapi P; Takenaka A; Sofikitis N
    Can J Urol; 2017 Dec; 24(6):9107-9113. PubMed ID: 29260636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin and nocturnal voiding dysfunction: Clinical evidence and safety profile in the treatment of nocturia.
    Chung E
    Expert Opin Pharmacother; 2018 Feb; 19(3):291-298. PubMed ID: 29376448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
    Fu FG; Lavery HJ; Wu DL
    Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
    Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ
    J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES; Raymond K; Andruczyk E; Juul KV
    Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice.
    Chen SL; Huang YH; Hung TW; Ou YC
    Int J Clin Pract; 2016 May; 70(5):372-9. PubMed ID: 27039892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
    Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
    J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.